NCT00336648 - Preop Chemoradiation Resectable Pancreas | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

September 30, 2007

Study Completion Date

July 31, 2008

Conditions

Pancreatic Neoplasms

Interventions

DRUG

Avastin (Bevacizumab)

10mg/kg by vein (IV) on Days 1, 2, 15 and 29 the adjuvant therapy every two weeks starting approximately 6 weeks after surgery for three months.

DRUG

Gemcitabine

400 mg/m2 IV once a week on Days 1, 2, 8,15, 22, 29, 36 +/-2 days (Saturdays)

PROCEDURE

Radiation Therapy

Day 3 +/-2 days (Monday) Start Radiation therapy, Mon -Fri x 28 days; 50.4 Gy prescribed to the 95% isodose at 1.8 Gy/fraction (28 fractions)

Trial Locations (1)

U.T. M.D. Anderson Cancer Center, Houston